Yuanlin Tang
Papers
1
Total Citations
40
H-Index
1
About
Yuanlin Tang is a pioneering researcher at the intersection of DNA nanotechnology and immunotherapy, whose work has opened new frontiers in targeted drug delivery and sepsis treatment. His most impactful contribution is the development of a DNA-based nanorobot capable of targeting, hitchhiking on, and regulating neutrophils—a breakthrough that addresses the critical challenge of delivering therapeutics to inflammatory sites in sepsis. This innovative platform, detailed in his 2025 paper, has already garnered 40 citations, reflecting its immediate resonance in the biomedical community. Tang’s research elegantly combines the programmability of DNA nanostructures with the natural homing abilities of immune cells, creating a versatile system that can modulate neutrophil activity to mitigate the hyperinflammatory response characteristic of sepsis. By engineering these nanorobots to actively “hitchhike” on neutrophils, his work bypasses traditional delivery barriers, offering a precision approach that could transform sepsis therapy. Tang’s contributions exemplify how bottom-up synthetic biology can address complex medical challenges, positioning him as a rising leader in nanomedicine and a key figure to watch for future advances in intelligent, cell-interfacing therapeutics.
Research Focus
Key Achievements
Top Papers
- 1